Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$249.67 - $299.48 $26.9 Million - $32.3 Million
-107,800 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$222.0 - $252.62 $29.8 Million - $34 Million
-134,430 Reduced 55.5%
107,800 $26.9 Million
Q3 2020

Nov 16, 2020

BUY
$175.56 - $226.45 $24.8 Million - $32 Million
141,500 Added 140.47%
242,230 $54.9 Million
Q2 2020

Aug 14, 2020

SELL
$118.84 - $189.72 $57.5 Million - $91.8 Million
-483,890 Reduced 82.77%
100,730 $17.6 Million
Q1 2020

May 15, 2020

BUY
$98.9 - $178.34 $40.5 Million - $73.1 Million
409,620 Added 234.07%
584,620 $73.8 Million
Q4 2019

Feb 14, 2020

SELL
$126.05 - $152.76 $24 Million - $29.1 Million
-190,360 Reduced 52.1%
175,000 $26.7 Million
Q3 2019

Nov 14, 2019

BUY
$125.07 - $143.67 $118,441 - $136,055
947 Added 0.26%
365,360 $48.4 Million
Q2 2019

Aug 14, 2019

BUY
$123.4 - $148.55 $45 Million - $54.1 Million
364,413 New
364,413 $51.7 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.38B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Health Cor Management, L.P. Portfolio

Follow Health Cor Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Health Cor Management, L.P. with notifications on news.